PEPENDIUM LABS

Saved source record

Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type
Original study
Study category (metadata hint)
Human
Published
2025-10-24
Authors
Goetz IA, Kanu C, Hoover A, Jimenez-Moreno C, Karn H, Kimel M, Neff LM, Boye KS.
Journal or registry
Not reported
Registry study design
Not reported
Registry enrollment
Not reported
Funding agencies
Eli Lilly and Company
Identifiers
DOI: 10.1016/j.obpill.2025.100220 · PMID: 41216380 · PMCID: PMC12596213
First found
Sep 25, 2026
Last found
Sep 25, 2026

Original sources

Browse saved studies · Search live sources